amount of 1,437,456,000 shares offered for initially offering to the public. Such ordinary shares have a par value of THB 5 per share, which was offered at the price of THB 5. 20 per share, totalling the

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

of July-December 2017 at Baht of 0.04 per share. The total outstanding shares entitled for the dividend is 4,554,643,575 shares and total dividend amount is Baht 182,185,743, the record date for the

increase of Baht 367 million, or 1.57 percent in net interest income derived from rising interest income and effective funding cost management. Meanwhile, operating expenses rose Baht 487 million, or 3.07

is not part of pass-through pricing formula with customers. Active dialogue is ongoing with customers to re- cover this cost increase. Aforesaid planned turnarounds in 2Q17 that impacted earnings, in

to levels last seen in 2015/16 as reflected in third quarter earnings. This has been achieved despite being negatively impacted by the cost increase from secondary raw material IPA by about $10 per ton

, and (2) the Company recorded the doubtful accounts on long-term loan to joint ventures of 910 million Baht in the same period last year. In Q2 2018, the Company had finance cost of 198 million Baht

amount of THB 259.36 million, or equivalent to the dividends at the rate of THB 0.036 per share (3.60 Satang per share) (There were 1,100 shares held by the shareholders who were disqualified to receive

Public Company Limited’s subsidiary company (“The Company”), Joint Venture Ureka UU co., ltd. (“UU”), in which the company hold 90% of the share. The company plans to increase the shareholding to 99%. On

direction primarily by considering the balance of three dimensions – economy, society and environment – under good corporate governance, appropriate risk management and effective cost management. At the same